Our Funds
![cultivate(MD) medical device venture capital logo](https://cultivate-md.com/wp-content/uploads/2023/04/cultivateMD-logo-transparent-250x56.png)
Seed Fund I
Established a portfolio of early stage medical device companies that looked to solve real problems.
![cultivate(MD) medical device venture capital logo](https://cultivate-md.com/wp-content/uploads/2023/04/cultivateMD-logo-transparent-250x56.png)
Seed Fund II
Created investment opportunities that allowed direct engagement into company operations.
![cultivate(MD) medical device venture capital logo](https://cultivate-md.com/wp-content/uploads/2023/04/cultivateMD-logo-transparent-250x56.png)
Accelerator
Continued investing in technologies that improve outcomes & reduce healthcare system costs.
![cultivate(MD) medical device venture capital logo](https://cultivate-md.com/wp-content/uploads/2023/04/cultivateMD-logo-transparent-250x56.png)
Opportunity
The Opportunity Fund leverages the foundation that the cultivate(MD) Seed and Accelerator Funds have built since 2017.
Our Funds
![cultivate(MD) medical device venture capital logo](https://cultivate-md.com/wp-content/uploads/2023/04/cultivateMD-logo-transparent-250x56.png)
Seed Fund I
Established a portfolio of early stage medical device companies that looked to solve real problems.
![cultivate(MD) medical device venture capital logo](https://cultivate-md.com/wp-content/uploads/2023/04/cultivateMD-logo-transparent-250x56.png)
Seed Fund II
Created investment opportunities that allowed direct engagement into company operations.
![cultivate(MD) medical device venture capital logo](https://cultivate-md.com/wp-content/uploads/2023/04/cultivateMD-logo-transparent-250x56.png)
Accelerator
Continued investing in technologies that improve outcomes & reduce healthcare system costs.
![cultivate(MD) medical device venture capital logo](https://cultivate-md.com/wp-content/uploads/2023/04/cultivateMD-logo-transparent-250x56.png)
Opportunity
The Opportunity Fund leverages the foundation that the cultivate(MD) Seed and Accelerator Funds have built since 2017.
![cultivateMD-logo-transparent white cultivate(MD) logo white](https://cultivate-md.com/wp-content/uploads/elementor/thumbs/cultivateMD-logo-transparent-white-qpuuavje89fqa9sgjakbmf7x9xcenvmag30ezbpz1s.png)
Representative Investments
![Embody is a cultivate(MD) portfolio company](https://cultivate-md.com/wp-content/uploads/2023/04/embody-foot-logo.png)
Embody
Embody, Inc., is a regenerative medicine company focused on the development and commercialization of implantable medical devices to address the unmet demands in soft tissue restoration and regeneration.
![Imascap is a cultivate(MD) portfolio company](https://cultivate-md.com/wp-content/uploads/2023/04/Imascap-1024x240.png)
Imascap
Imascap develops software for preoperative planning of shoulder replacement surgery.
![Shoulder Innovations is a cultivate(MD) portfolio company](https://cultivate-md.com/wp-content/uploads/2023/04/Shoulder-Innovations-cultivateMD--1024x233.png)
Shoulder Innovations
Shoulder Innovations’ InSet™ Total Shoulder Replacement System addresses the most significant issue in shoulder arthroplasty: unreliable fixation of the glenoid implant.
News and Updates
![Shoulder Innovations](https://cultivate-md.com/wp-content/uploads/2022/03/si-cultivateMD-news_.png)
Shoulder Innovations Further Strengthens IP Portfolio in Key Areas with Recent Patent Grants
Grand Rapids, MI – July 24, 2024 – Shoulder Innovations, a cultivate(MD) portfolio company and leader in shoulder replacement technology, today announced the United States Patent
![SentiAR is a cultivate(MD) portfolio company](https://cultivate-md.com/wp-content/uploads/2023/04/SentiAR-cultivateMD-news.jpg)
New Jersey’s First Holographic Cardiac Ablation Guided by SentiAR’s CommandEP
cultivate(MD) is excited announce a significant milestone achieved by one of our portfolio companies, SentiAR. The Valley Hospital in Ridgewood, New Jersey, has become the first
![cultivate(MD) SPDx news](https://cultivate-md.com/wp-content/uploads/2023/02/cultivateMD-SPDx-news.png)
Sterile Processing Express (SPDx) Achieves Advanced Sterile Processing Certification from DNV GL
Grand Rapids, Mich., June 13, 2024 — Sterile Processing Express (SPDx) announced today that it has achieved a major milestone in its healthcare business development. SPDx
![Virtual Incision cultivate(MD)](https://cultivate-md.com/wp-content/uploads/2024/01/Virtual-IncisionMira.png)
Virtual Incision Receives FDA Authorization for the First Miniaturized Robotic-Assisted Surgery Device
Grand Rapids, MI., February 27, 2024 – Virtual Incision, a cultivate(MD) portfolio company, has been granted marketing authorization of the MIRA™ Surgical System (MIRA) from the FDA.
![Virtual Incision cultivate(MD)](https://cultivate-md.com/wp-content/uploads/2024/01/Virtual-IncisionMira.png)
Virtual Incision’s Mini Surgical Robot Heads to Space
The spaceMIRA, a groundbreaking surgical robot, embarks on a historic journey to the International Space Station, a collaborative effort involving the University of Nebraska and